We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Caliber Imaging & Diagnostics Stock

Invest in or calculate the value of your shares in Caliber Imaging & Diagnostics or other pre-IPO companies through EquityZen's platform.

Get Started

Caliber Imaging & Diagnostics Stock (CIMD)

Based in New York in the USA, Caliber I.D. is a medical technologies company that designs, develops, and markets innovative imaging

About Caliber Imaging & Diagnostics Stock

Founded

1991

Headquarters

Rochester, NY, US

Total Funding

5.0M

Industries

Software, Artificial Intelligence, Data and Analytics

Based in New York in the USA, Caliber I.D. is a medical technologies company that designs, develops, and markets innovative imaging solutions that shows tissue at the cellular level. Founded in 1991 as Lucid Technologies, Inc. and later Lucid, Inc., Caliber Imaging & Diagnostics, Inc. is currently the only company in the world to offer in vivo confocal microscopes designed specifically for imaging skin and other tissue. Caliber I.D.’s Rapid Cell ID technology enables scientists and physicians to characterize intact normal and abnormal cellular architecture that is otherwise invisible to the naked eye.

Caliber Imaging & Diagnostics Management

Leadership team at Caliber Imaging & Diagnostics

CTO

William J. Fox

CEO

L. Michael Hone

Locked Features

Join now and verify your accreditation status to gain access to:

  • Caliber Imaging & Diagnostics current valuation
  • Caliber Imaging & Diagnostics stock price
  • Available deals in Caliber Imaging & Diagnostics and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Caliber Imaging & Diagnostics stock?

Accredited investors can buy pre-IPO stock in companies like Caliber Imaging & Diagnostics through EquityZen funds. These investments are made available by existing Caliber Imaging & Diagnostics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Caliber Imaging & Diagnostics stock?

Shareholders can sell their Caliber Imaging & Diagnostics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."